Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activityCHEN, Kuen-Feng; PAO, Kuan-Chuan; SU, Jung-Chen et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 20, pp 6144-6153, issn 0968-0896, 10 p.Article

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cellsCHEN, K.-F; LIU, C.-Y; LIN, Y.-C et al.Oncogene (Basingstoke). 2010, Vol 29, Num 47, pp 6257-6266, issn 0950-9232, 10 p.Article

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancerBÖCKELMAN, C; HAGSTRÖM, J; MÄKINEN, L. K et al.British journal of cancer. 2011, Vol 104, Num 12, pp 1890-1895, issn 0007-0920, 6 p.Article

Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survivalREN, J; LI, W; YAN, L et al.British journal of cancer. 2011, Vol 105, Num 12, pp 1905-1911, issn 0007-0920, 7 p.Article

CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutationWANG, Cheng-Yi; CHAO, Ting-Ting; CHANG, Fang-Yu et al.Lung cancer. 2014, Vol 85, Num 2, pp 152-160, issn 0169-5002, 9 p.Article

CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cellsLIN, Yu-Chin; CHEN, Kuei-Chiu; CHEN, Ching-Chow et al.Oral oncology (1997). 2012, Vol 48, Num 7, pp 585-593, issn 1368-8375, 9 p.Article

Prognostic role of CIP2A expression in serous ovarian cancerBÖCKELMAN, C; LASSUS, H; HEMMES, A et al.British journal of cancer. 2011, Vol 105, Num 7, pp 989-995, issn 0007-0920, 7 p.Article

CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor CellsWENJUAN LI; ZHENG GE; CHENG LIU et al.Clinical cancer research. 2008, Vol 14, Num 12, pp 3722-3728, issn 1078-0432, 7 p.Article